Noninvasive Neuromodulation

Thursday, January 22, 2026

10:30 AM - 11:15 AM PST

Location: Milano Ballroom I & II

Session

Description: The neuromodulation industry continues to face challenges presented by cuts in government funding, loss of knowledgeable regulatory personnel, and faulty assessments from poorly informed and conflicted critics. But a new sense of unity among clinicians in varying specialties, professional organizations, and patient advocacy groups will continue to push forward to keep the field growing.

Pre-Conference Course Speaker(s)

Jeremy Koff, MPA, MBA (he/him/his)

Sr. Consulting Editor
Neurotech Reports
Studio City, California, United States

Pre-Conference Course Industry Speaker(s)

Colin Kealey, MD

CEO
NeuroSigma
Los Angeles, California, United States
Amy Baxter, MD (she/her/hers)

Professor/CEO
Augusta University/Harmonic Scientific
Atlanta, Georgia, United States
Ken Mariash

CEO
Sinaptica Therapeutics, Inc